Cimduo Tablet, Film Coated
Product Images NDC 49502-450

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Cimduo (NDC 49502-450). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Viatris Specialty Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cimduo 300 mg/300 mg Carton Label (Image 01)

CIMDUO 300 mg/300 mg film-coated tablets carton label for oral use. Contains lamivudine and tenofovir disoproxil fumarate. The label shows 30 tablets per package. Manufactured for Mylan Specialty L.P., Morgantown, WV, USA, and made in India. Includes dosage instructions, storage conditions, and barcode. Label prominently features the Mylan logo and NDC 49502-450-93.*

FDA Label Image

Lamivudine Structural Formula (Image 02)

Chemical structure diagram of the active ingredient Lamivudine, showing its molecular components and bonds as depicted in the image.*

FDA Label Image

Tenofovir Structural Formula (Image 03)

Chemical structure diagram of tenofovir disoproxil fumarate, showing atoms and bonds including a purine base, phosphonate group, and ester substituents. A molecular representation includes the fumarate part as two carboxylic acid groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.